J.P. Morgan Meets With Allscripts Healthcare Solutions (MDRX)

J.P. Morgan met with Glen Tullman, CEO of Allscripts Healthcare Solutions

and Seth Frank (

) in New York yesterday and reitereated their Overweight rating. In a note to clients, J.P. Morgan writes, "We reiterate our OW recommendation on MDRX, which trades at 19.9x our 2011 EPS estimate. We view this as an attractive valuation for a company expected to grow earnings around 22-23% over the next few years." MDRX is trading at $17.89.